| 1 |
35455696 | The Influence of the CES1 Genotype on the Pharmacokinetics of Enalapril in Patients with Arterial Hypertension. | 2022 Apr 5 |
5 |
| 2 |
33963573 | Effect of CES1 genetic variation on enalapril steady-state pharmacokinetics and pharmacodynamics in healthy subjects. | 2021 Dec |
6 |
| 3 |
28639420 | The Pharmacokinetics of Enalapril in Relation to CES1 Genotype in Healthy Danish Volunteers. | 2017 Dec |
3 |
| 4 |
26076923 | CES1 genetic variation affects the activation of angiotensin-converting enzyme inhibitors. | 2016 Jun |
2 |
| 5 |
25832562 | Absorption and cleavage of enalapril, a carboxyl ester prodrug, in the rat intestine: in vitro, in situ intestinal perfusion and portal vein cannulation models. | 2015 Sep |
2 |
| 6 |
25919042 | Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalapril. | 2015 Nov |
4 |
| 7 |
24141856 | In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors. | 2014 Jan |
3 |